Background: Our single-institution series, now including 53 metastatic MLS patients (pts) treated with trabectedin (T), was reviewed focusing on the use of surgery of residual disease. Methods: Since ...
ROCHELLE PARK, NJ, UNITED STATES, December 4, 2024 /EINPresswire.com/ -- i3 Health ® and Oncology Data Advisor ® are pleased to announce the publication of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback